<- Go Home
Renex Corp.
Renex Corp. provides dialysis and ancillary services to patients suffering from end-stage renal disease or acute renal failure as a result of trauma or other illnesses. As of 02/01/2000, Renex Corp. operates as a subsidiary of National Nephrology Associates, Inc.
Market Cap
$68.4M
Volume
24.1K
Cash and Equivalents
$10.2M
EBITDA
$6.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$11.1M
Profit Margin
24.60%
52 Week High
$10.00
52 Week Low
$3.50
Dividend
N/A
Price / Book Value
2.27
Price / Earnings
23.91
Price / Tangible Book Value
3.25
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$3.3M
Return on Equity
11.90%
Return on Assets
5.63
Cash and Short Term Investments
$10.2M
Debt
$1.7M
Equity
$27.3M
Revenue
$45.1M
Unlevered FCF
$4.6M
Sector
Health Care Providers and Services
Category
N/A